Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Possible Metabolic Alterations among Autistic Male Children: Clinical and Biochemical Approaches.

Tytuł:
Possible Metabolic Alterations among Autistic Male Children: Clinical and Biochemical Approaches.
Autorzy:
Hassan MH; Department of Medical Biochemistry, Faculty of Medicine, South Valley University, Qena, Egypt. .
Desoky T; Department of Neuropsychiatry, Faculty of Medicine, South Valley University, Qena, Egypt.
Sakhr HM; Department of Pediatrics, Faculty of Medicine, South Valley University, Qena, Egypt.
Gabra RH; Department of Neuropsychiatry, Faculty of Medicine, Assiut University, Assiut, Egypt.
Bakri AH; Department of Pediatrics, Faculty of Medicine, South Valley University, Qena, Egypt.
Źródło:
Journal of molecular neuroscience : MN [J Mol Neurosci] 2019 Feb; Vol. 67 (2), pp. 204-216. Date of Electronic Publication: 2019 Jan 02.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Publication: Totowa, NJ : Humana Press
Original Publication: Boston : Birkhäuser [i.e. Cambridge, MA : Birkhäuser Boston, c1989-
MeSH Terms:
Metabolome*
Autistic Disorder/*blood
Adenosine Deaminase/blood ; Antigens, Bacterial/analysis ; Autistic Disorder/physiopathology ; Biomarkers/blood ; Child ; Child, Preschool ; Cholesterol/blood ; Gonadal Steroid Hormones/blood ; Helicobacter pylori/immunology ; Humans ; Hydrocortisone/blood ; Male ; Metals, Heavy/blood ; Mitochondria/metabolism ; Oxidative Stress
References:
Dev Neurosci. 2000;22(4):320-8. (PMID: 10965154)
Neurogenetics. 2001 Mar;3(2):111-3. (PMID: 11354825)
Am J Occup Ther. 2001 Jul-Aug;55(4):416-23. (PMID: 11723986)
J Nerv Ment Dis. 1975 Sep;161(3):180-4. (PMID: 1176974)
Curr Gastroenterol Rep. 2002 Jun;4(3):251-8. (PMID: 12010627)
Neuro Endocrinol Lett. 2002 Aug;23(4):325-8. (PMID: 12195235)
J Child Psychol Psychiatry. 2002 Nov;43(8):1087-98. (PMID: 12455929)
J Autism Dev Disord. 2002 Oct;32(5):397-422. (PMID: 12463517)
Brain Res Bull. 2003 Aug 15;61(3):227-8. (PMID: 12909291)
J Autism Dev Disord. 2003 Aug;33(4):443-8. (PMID: 12959423)
Science. 1956 Feb 24;123(3191):309-14. (PMID: 13298683)
J Autism Dev Disord. 2003 Dec;33(6):631-42. (PMID: 14714932)
J Autism Dev Disord. 2004 Dec;34(6):615-23. (PMID: 15679182)
Behav Cogn Neurosci Rev. 2005 Mar;4(1):43-58. (PMID: 15886402)
Autism. 2005 Jul;9(3):290-8. (PMID: 15937043)
Environ Toxicol. 2005 Aug;20(4):402-6. (PMID: 16007643)
Neuro Endocrinol Lett. 2005 Oct;26(5):439-46. (PMID: 16264412)
Neurotoxicology. 2006 Mar;27(2):210-6. (PMID: 16310252)
J Child Neurol. 2006 Feb;21(2):170-2. (PMID: 16566887)
Minerva Pediatr. 2006 Apr;58(2):109-20. (PMID: 16835571)
Am J Med Genet B Neuropsychiatr Genet. 2006 Sep 5;141B(6):666-8. (PMID: 16874769)
Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):947-56. (PMID: 16917939)
Am J Occup Ther. 2007 Mar-Apr;61(2):190-200. (PMID: 17436841)
J Toxicol Environ Health A. 2007 Jun;70(12):1046-51. (PMID: 17497416)
Neuro Endocrinol Lett. 2007 Aug;28(4):445-8. (PMID: 17693971)
Eur Child Adolesc Psychiatry. 2008 Feb;17(1):39-43. (PMID: 17876507)
Mol Genet Metab. 2008 May;94(1):16-37. (PMID: 18243024)
J Neuroimmunol. 2008 Nov 15;204(1-2):149-53. (PMID: 18762342)
J Neurol Sci. 2009 May 15;280(1-2):101-8. (PMID: 18817931)
PLoS One. 2008;3(11):e3815. (PMID: 19043581)
J Autism Dev Disord. 2009 Apr;39(4):678-82. (PMID: 19052857)
Neurosci Lett. 2011 Jan 7;487(2):129-33. (PMID: 19563863)
Prostaglandins Leukot Essent Fatty Acids. 2009 Oct;81(4):253-64. (PMID: 19608392)
Altern Med Rev. 2010 Apr;15(1):15-32. (PMID: 20359266)
Biochim Biophys Acta. 2010 Jun-Jul;1797(6-7):1130-7. (PMID: 20441769)
Neuro Endocrinol Lett. 2010;31(6):837-41. (PMID: 21196912)
Mol Psychiatry. 2012 Mar;17(3):290-314. (PMID: 21263444)
Autism Res. 2011 Jun;4(3):163-76. (PMID: 21465671)
J Autism Dev Disord. 2012 Mar;42(3):367-77. (PMID: 21519954)
PLoS Biol. 2011 Jun;9(6):e1001081. (PMID: 21695109)
Arch Sex Behav. 2012 Jun;41(3):571-81. (PMID: 22033667)
J Bacteriol. 2012 Feb;194(4):839-54. (PMID: 22194455)
Neurosciences (Riyadh). 2005 Jul;10(3):213-8. (PMID: 22473261)
PLoS One. 2012;7(6):e38727. (PMID: 22701700)
Acta Neurobiol Exp (Wars). 2012;72(2):113-53. (PMID: 22810216)
Int J Environ Res Public Health. 2013 Aug 20;10(8):3771-800. (PMID: 23965928)
EMBO J. 2014 Jul 1;33(13):1454-73. (PMID: 24825347)
J Pak Med Assoc. 2014 Apr;64(4):423-7. (PMID: 24864637)
Mol Autism. 2014 Sep 09;5(1):46. (PMID: 25221668)
Res Dev Disabil. 2015 Mar;38:202-12. (PMID: 25575284)
Microb Ecol Health Dis. 2015 May 07;26:27458. (PMID: 25956238)
Front Neurosci. 2015 Sep 24;9:313. (PMID: 26483618)
Behav Neurol. 2015;2015:545674. (PMID: 26508811)
Braz J Microbiol. 2016 Jan-Mar;47(1):167-71. (PMID: 26887240)
In Vitro Cell Dev Biol Anim. 2016 Jun;52(6):625-31. (PMID: 26896067)
Neuroscience. 2016 Jun 2;324:131-9. (PMID: 26964681)
J Trace Elem Med Biol. 2016 Sep;37:8-24. (PMID: 27473827)
PLoS One. 2016 Nov 8;11(11):e0164153. (PMID: 27824861)
Sci Rep. 2017 Mar 02;7:43608. (PMID: 28252669)
Autism Res. 2017 Jun;10(6):1022-1044. (PMID: 28401679)
Physiol Rev. 1987 Apr;67(2):440-519. (PMID: 2882529)
Metab Brain Dis. 2017 Dec;32(6):1983-1997. (PMID: 28831647)
Neuropsychiatr Dis Treat. 2017 Sep 14;13:2397-2403. (PMID: 28979127)
Mol Brain. 2018 Jan 4;11(1):1. (PMID: 29301575)
J Clin Endocrinol Metab. 1988 Jul;67(1):186-90. (PMID: 2967851)
J Mol Neurosci. 2018 Jul;65(3):265-276. (PMID: 29931502)
J Nutr. 1985 Apr;115(4):516-23. (PMID: 3981272)
J Lab Clin Med. 1971 Oct;78(4):664-74. (PMID: 5000359)
Dev Psychobiol. 1977 Nov;10(6):579-83. (PMID: 563824)
J Am Acad Child Psychiatry. 1982 Jan;21(1):71-4. (PMID: 7096833)
J Neurochem. 1994 Dec;63(6):2172-8. (PMID: 7964737)
Clin Chim Acta. 1994 Sep;229(1-2):205-7. (PMID: 7988051)
Biol Psychiatry. 1993 Jun 1-15;33(11-12):762-73. (PMID: 8373914)
J Autism Dev Disord. 1995 Dec;25(6):641-54. (PMID: 8720032)
Curr Opin Neurobiol. 1997 Apr;7(2):157-63. (PMID: 9142758)
Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8836-41. (PMID: 9238064)
J Child Psychol Psychiatry. 1997 Sep;38(6):705-15. (PMID: 9315980)
QJM. 1997 Nov;90(11):657-67. (PMID: 9474346)
Contributed Indexing:
Keywords: Abnormal metabolism; Autism; Biochemical assessments; CARS; IQ; SSP
Substance Nomenclature:
0 (Antigens, Bacterial)
0 (Biomarkers)
0 (Gonadal Steroid Hormones)
0 (Metals, Heavy)
97C5T2UQ7J (Cholesterol)
EC 3.5.4.4 (Adenosine Deaminase)
WI4X0X7BPJ (Hydrocortisone)
Entry Date(s):
Date Created: 20190103 Date Completed: 20190219 Latest Revision: 20200225
Update Code:
20240105
DOI:
10.1007/s12031-018-1225-9
PMID:
30600432
Czasopismo naukowe
The present cross-sectional, hospital-based study was carried out on 146 Egyptian male children, 73 males with autism who were comparable with another 73 healthy age- and sex-matched children, recruited from the outpatients' psychiatric clinics of the Neuropsychiatric and Pediatric Departments of South Valley and Assiut University Hospitals, Egypt. Neuropsychological assessments of autistic males were done using CARS, short sensory profile and intelligent quotients. Serum markers of mitochondrial dysfunction (lactate, pyruvate, and lactate to pyruvate ratio, creatine kinase (CK), L-carnitine, ammonia, lactate dehydrogenase, pyruvate kinase, alanine transaminase and aspartate transaminase), oxidative stress and blood levels of heavy metals (mercury, lead and aluminium) were measured. Serum cholesterol, cortisol, free testosterone, estradiol, dehydroepiandrostenedione, adenosine deaminase and Helicobacter pylori antigen in stool were also performed. There was evidence of mitochondrial dysfunction among autistic children. Additionally, there were significantly lower serum total cholesterol, cortisol and estradiol as well as significantly higher dehydroepiandrostenedione (DHEA) and free testosterone (p < 0.05 for all markers). Twenty-eight (38%) cases were positive for H. pylori antigen in their stool with significant higher serum ammonia and lower adenosine deaminase than in H. pylori-negative autistic children. Mitochondrial dysfunction, H. pylori infection and low cholesterol were prevalent among autistic male children, which should be targeted during autism management.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies